한글목차

면역 레퍼토리 시퀀싱 시장은 2026년에 1억 8,110만 달러로 추정되며, 2033년까지 2억 6,300만 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 5.6%를 나타낼 전망입니다.

면역 레퍼토리란 생물의 면역체계가 생성하는 아형 단백질을 말합니다. 척추동물의 면역체계에는 6가지 주요 단백질, 즉 2가지 면역글로불린과 4가지 T세포 수용체가 존재합니다. 면역 레퍼토리 시퀀싱 기술을 통해 연구자와 과학자들은 적응 면역과 관련된 질병을 조사하고 이해할 수 있습니다. 면역 레퍼토리 시퀀싱은 바이오마커 발굴, 감염질환 연구, 천식 및 알레르기 연구, 암 면역치료 등에 널리 응용되고 있습니다.

시장 역학

세계적으로 암 발병률이 증가함에 따라 면역 레퍼토리 시퀀싱 시장의 성장이 촉진될 것으로 예측됩니다. 미국 국립암연구소(2016)에 따르면, 미국에서는 약 1,680만 건의 신규 암이 진단되었고, 약 59만 5,690명이 암으로 사망했습니다. 또한, 2024년까지 암 환자 수는 1,900만 명에 달할 것으로 예측되고 있습니다. 2012년판 '암 아틀라스'에 따르면, 라틴아메리카 및 카리브해 지역에서는 연간 약 110만 건의 신규 암 발생과 60만 건의 암 사망이 보고되고 있으며, 폐암은 남녀 모두 암 사망의 주요 원인으로 꼽히고 있습니다.

그러나 특정 시퀀싱 플랫폼 및 데이터 분석 서비스와 관련된 높은 비용, 제품 리콜 등의 요인으로 인해 예측 기간 동안 면역 레퍼토리 시퀀싱 시장의 성장이 저해될 것으로 예측됩니다. 예를 들어, 2015년 일루미나사는 MiSeqDx 장비에서 사용 시 소프트웨어 제한이 발생하여 일루미나 MiSeqDx 유니버설 키트 1.0을 리콜한 바 있습니다. 이 소프트웨어는 프라이머와 관련된 특정 유전체 위치의 삽입이나 결실을 보고할 수 없었습니다.

본 조사의 주요 특징

• 이 보고서는 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 면역 레퍼토리 시퀀싱 시장의 상세한 분석, 시장 규모 및 CAGR(%)을 조사하여 전해드립니다.
• 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 또는 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략에 대한 중요한 정보도 제공합니다.
• 이 보고서는 기업 개요, 재무 성과, 제품 포트폴리오, 지리적 확장, 유통 전략, 주요 개발 및 전략과 같은 매개 변수를 기반으로 세계 면역 레퍼토리 시퀀싱 시장의 주요 업체를 프로파일링합니다.
• 이 보고서는 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 정부 정책, 기술 업그레이드, 시장 확대, 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
• 이 세계 면역 레퍼토리 시퀀싱 시장 보고서는 투자자, 제품 제조업체, 유통업체, 공급업체, 연구 및 컨설팅 회사, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자에게 유용하게 활용될 수 있습니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 개요

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 면역 레퍼토리 시퀀싱 시장 : 제품 유형별, 2026년-2033년

제5장 세계의 면역 레퍼토리 시퀀싱 시장 : 용도별, 2026년-2033년

제6장 세계의 면역 레퍼토리 시퀀싱 시장 : 최종사용자별, 2026년-2033년

제7장 세계의 면역 레퍼토리 시퀀싱 시장 : 지역별, 2026년-2033년

제8장 경쟁 구도

제9장 섹션

영문목차

Immune Repertoire Sequencing Market is estimated to be valued at USD 181.1 Mn in 2026 and is expected to reach USD 263.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

Immune repertoire refers to sub-type protein that an organism's immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study

• This report provides in-depth analysis of the immune repertoire sequencing market, market size (USD Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global immune repertoire sequencing market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• By Product Type
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
• By Application
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
• By End User
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players Insights
  • Thermo Fisher Scientific, Inc.,
  • Illumina Inc.
  • ArcherDX, Inc.
  • Roche Holding AG
  • Pacific Biosciences
  • CD Genomics, Atreca, Inc.
  • Adaptive Biotechnologies
  • Oxford Nanopore Technologies, Ltd.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Takara Bio, Inc.

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Landscape
• Product Recall
• Epidemiology Analysis
• Technology Overview
• PEST Analysis
• Porter's Five Forces model

4. Global Immune Repertoire Sequencing Market, By Product Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Assay Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• T-Cell Receptor (TCR) Kits
• B-Cell Receptor (BCR) Kits
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Immune Repertoire Sequencing Market, By Application, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Cancer Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Biomarker Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Vaccine Development and Efficacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Transplant Rejection and Tolerance
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Immune Repertoire Sequencing Market, By End User, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Diagnostic Labs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Immune Repertoire Sequencing Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, By Region, 2026 - 2033
  • Regional Trends
• North America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Africa
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa
• Middle East
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Application, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East

8. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Illumina Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • ArcherDX, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Roche Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Pacific Biosciences
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • CD Genomics
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Atreca, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Adaptive Biotechnologies
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Oxford Nanopore Technologies, Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Agilent Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Takara Bio, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact